FinTechFunding

Palla Pharma: Enters sale and leaseback of Coolaroo site

Palla Pharma Enters sale and leaseback of Coolaroo site

  • Palla Pharma (PAL) enters into a sale and leaseback agreement of its $33.1 million manufacturing site in Melbourne
  • Upon receiving funds for the Coolaroo location, the company made a gain of around $21 million
  • Palla retains acess to $5 million of undrawn capacity under its existing credit facility
  • The 18-month lease arrangement, with an option to extend for six months, allows continued site access
  • PallaPharma shares are in the green, up 2.6 per cent, trading at 40 cents at 2:08 pm AEDT
Previous article
Horseshoe Metals: Completes ASX requirements for potential relisting
Next article
Seeded Network: Raises $1.25M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...
FinTech

Hacked DeFi Platform Drift Secures Funds to Repay Customers

Drift plans to relaunch with Tether support after addressing security issues.Highlights: Drift DeFi platform has secured funds after...
FinTech

Business Banking Fintech Slash Reaches Unicorn Status

The fintech startup achieves a valuation of over $1 billion.Highlights: Slash has been valued at over $1 billion.The...
FinTech

Amex Strengthens Digital Services with AI Expense Management Acquisition

American Express to acquire Hyper to enhance its business offerings.Highlights: American Express announces the acquisition of AI startup...